| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 3.8% stake in PMV Pharmaceuticals, Inc. |
| 02/10/2023 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 2.6% stake in Doximity, Inc. |
| 02/10/2023 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 8.5% stake in Sera Prognostics, Inc. |
| 02/14/2022 |
SC 13G
| INTERWEST PARTNERS X LP reports a 8.6% stake in Sera Prognostics, Inc. |
| 02/14/2022 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 7.2% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G
| INTERWEST PARTNERS X LP reports a 7.9% stake in Doximity, Inc. |
| 02/14/2022 |
SC 13G
| INTERWEST PARTNERS X LP reports a 25.4% stake in Braze, Inc. |
| 02/14/2022 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 0% stake in Reshape LifeSciences, Inc. |
| 08/11/2021 |
SC 13D/A
| INTERWEST PARTNERS X LP reports a 1.9% stake in Cidara Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G
| INTERWEST PARTNERS X LP reports a 14.5% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G
| INTERWEST PARTNERS X LP reports a 7.8% stake in The RealReal, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/29/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/24/2018 |
SC 13D/A
| INTERWEST PARTNERS X LP reports a 9.5% stake in Eiger BioPharmaceuticals, Inc. |
| 08/31/2018 |
SC 13G/A
| INTERWEST PARTNERS X LP reports a 15.2% stake in Obalon Therapeutics, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 04/01/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 07/13/2012 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |